BioMers partners with China Pioneer Pharma Holdings Ltd to bring SimpliClear ® into Hong Kong

Simpliclear logoSingapore – 14 January 2014
BioMers continues its international expansion through a partnership with China Pioneer Pharma Holdings Ltd. The new market of entry for SimpliClear® is Hong Kong. With a high demand for aesthetic orthodontics, Hong Kong represents an ideal opportunity for SimpliClear®. The commercial campaign has begun with the product being available to patients and doctors.

China Pioneer Pharma Holdings Ltd. is based in Shanghai, China. The company promotes a large number of pharmaceutical products and medical devices throughout China and other Asian countries, including numerous dental brands. It recently went public on the Hong Kong Stock Exchange, raising around 1.3 billion HK$ for its further expansion.

“We are convinced of the value proposition of SimpliClear®, bringing a unique solution for aesthetic orthodontic treatment – braces that are nearly invisible – to the patient and doctor”, said Mr Vincent Yuen, Managing Director, Pioneer Medical SEA.
“The partnership marks the entry of our company into another important market. China Pioneer Pharma Holdings Ltd. offers an extensive sales and distribution network, which is a great platform for our highly innovative product. The partnership brings the potential for further collaboration in other countries in the region in the very near future”, said Mr George Aliphtiras, CEO BioMers.

About BioMers : BioMers Pte. Ltd. is a Singapore-based medical device company that has developed novel polymer composite products for numerous biomedical applications. The company’s flagship product is the SimpliClear® braces system, which is the world’s first and only aesthetic solution for all types of orthodontic treatments. This translucent, almost invisible braces system is customized to each patient, providing faster and better results. Established in 2005, BioMers is a spin-off company from the National University of Singapore, where the technology was invented. BioMers has received seed funding from NUS Enterprise, venture capital funding from the Nanostart Singapore Early Stage Venture Fund, and grants from government agencies, including SPRING Singapore and the Economic Development Board.
For more information, visit:

About China Pioneer Pharma : China Pioneer Pharma Holdings Ltd is one of the largest comprehensive marketing, promotion and channel management service providers dedicated to imported pharmaceutical products and medical devices in China. Founded in 1996, Pioneer has been growing fast. Today, the company has established a nationwide marketing, promotion and channel management service network covering over 20,000 hospitals and other medical institutions across 31 provinces, municipalities and autonomous regions in China. Pioneer’s business headquarters are located in Shanghai, the commercial center of China, and the logistics hub is located in Hubei province, one of the best connected and centrally located areas in the country.
For more information, visit:

your ad here